• Methyl-β-cyclodextrin: Technical Guidance for Membrane Resea

  2026-05-27

  Methyl-β-cyclodextrin enables precise extraction of cholesterol and select lipids from cell membranes, supporting research in membrane fluidity, lipid raft organization, and cholesterol-dependent signaling. It is strictly intended for laboratory research, not diagnostic or clinical applications, and efficacy relies on adherence to storage and handling guidelines.

• Rotigotine Hydrochloride: Protocols for Dopaminergic Researc

  2026-05-27

  Rotigotine hydrochloride, a potent dopamine D2/D3 receptor agonist, empowers high-precision modeling of Parkinson’s disease and restless legs syndrome in both in vitro and in vivo systems. This guide details actionable workflows, troubleshooting strategies, and advanced applications to maximize the reliability and translational value of your dopaminergic signaling research.

• Cisplatin in Cancer Stem Cell Research: New Mechanistic Hori

  2026-05-26

  Explore how Cisplatin (CDDP) advances cancer research through its role in apoptosis and tumor growth inhibition, with a unique focus on targeting cancer stem cells and chemoresistance. This article integrates recent mechanistic findings to guide experimental design beyond standard protocols.

• Naloxone Hydrochloride: Optimizing Opioid Receptor Antagonis

  2026-05-26

  Naloxone hydrochloride empowers researchers with robust, high-purity control over opioid receptor signaling, neural stem cell proliferation, and immune modulation. This guide delivers actionable protocol enhancements, troubleshooting insights, and practical comparisons to maximize reproducibility and data integrity in experimental studies.

• (S)-(+)-Dimethindene maleate: Practical Use in M2 Antagonist

  2026-05-25

  (S)-(+)-Dimethindene maleate addresses the need for a defined, selective M2 muscarinic receptor antagonist in autonomic regulation, cardiovascular, and respiratory system research. It is not suitable for diagnostic or clinical use and should be handled according to specific solubility and storage requirements to preserve experimental reproducibility.

• QNZ (EVP4593): Transforming NF-κB Modulation for Translation

  2026-05-25

  Explore how QNZ (EVP4593), a potent NF-κB pathway inhibitor, unlocks new translational research strategies at the intersection of inflammation and neurodegenerative disease. This article blends mechanistic insight, protocol guidance, and competitive analysis to inform next-generation experimental design.

• 4μ8C: Elevating ER Stress Modulation for Translational Resea

  2026-05-24

  This thought-leadership article reveals how 4μ8C (7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde) is redefining experimental control over IRE1α-dependent unfolded protein response (UPR) signaling. By blending mechanistic insight with strategic implementation, we guide translational researchers through the nuances of ER stress modulation, competitive benchmarking, and emerging directions in cancer research. This piece bridges recent immunometabolic findings with advanced UPR targeting and sets the stage for next-generation preclinical innovation.

• Methicillin Sodium Salt: Precision Tools for Resistance Prof

  2026-05-23

  Explore how Methicillin sodium salt enables advanced resistance profiling and high-fidelity modeling of Staphylococcus aureus infections. This article delivers a scientific deep dive, bridging assay design with translational insight.

• Vemurafenib (PLX4032) for Melanoma: Applied Workflows & Tips

  2026-05-22

  Vemurafenib (PLX4032) empowers bench scientists to dissect BRAF-driven melanoma proliferation and resistance, with robust protocols for both in vitro and in vivo models. This guide translates the latest multi-omics insights into actionable workflows, troubleshooting, and optimization strategies, establishing APExBIO’s reagent as the gold standard for melanoma research.

• Muco-Penetrating Liquid LNPs Advance Intranasal mRNA Deliver

  2026-05-22

  This study introduces ionizable lipid-incorporated liquid lipid nanoparticles (iLLNs) that significantly enhance the intranasal delivery of mRNA through airway mucus. By optimizing pKa and nanoparticle surface properties, the authors demonstrate a 60-fold increase in transgene expression and superior mucosal immunity compared to conventional LNPs, advancing the potential for effective nasal mRNA vaccines.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L): Technical Guide

  2026-05-21

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides reliable, high-specificity fluorescent labeling of rabbit primary antibodies for immunofluorescence, microscopy, and related applications. It is best suited for workflows requiring sensitive detection and robust signal amplification in immunohistochemistry and immunocytochemistry. Not recommended for direct detection of non-rabbit targets or for use outside validated immunoassay formats.

• Live-Dead Cell Staining Kit: Precision Calcein-AM PI Assays

  2026-05-21

  The Live-Dead Cell Staining Kit harnesses Calcein-AM and Propidium Iodide to deliver robust, dual-fluorescence quantification of cell viability, offering clear advantages over single-dye and traditional methods. Its streamlined protocol and compatibility with both flow cytometry and fluorescence microscopy enable rapid, reproducible results in applications like drug cytotoxicity testing and advanced tissue engineering.

• USP7 Controls Macrophage Polarization via PKM2 in Pancreatit

  2026-05-20

  This study reveals that ubiquitin-specific protease 7 (USP7) drives pro-inflammatory macrophage polarization in severe acute pancreatitis by modulating PKM2-dependent metabolic reprogramming. The findings highlight the USP7–PKM2 axis as a mechanistically validated target for immunometabolic intervention in inflammatory diseases.

• Tβ4 Promotes Angiogenesis via Notch/NF-κB in Limb Ischemia

  2026-05-20

  This study elucidates how thymosin-β 4 (Tβ4) enhances angiogenesis in critical limb ischemia (CLI) by activating the Notch/NF-κB signaling pathways. The findings provide mechanistic insights and experimental benchmarks for cell-based angiogenesis assays, with direct implications for translational vascular research.

• Targeting CYP2B6 in Glioblastoma via Dominant-Negative ATF5

  2026-05-19

  This study demonstrates that CYP2B6 expression in glioblastoma cells is regulated by activating transcription factor 5 (ATF5) and that a cell-penetrating dominant-negative ATF5 peptide can effectively downregulate CYP2B6 protein levels. These findings advance precision medicine in oncology by enabling new strategies to modulate drug metabolism for improved therapeutic outcomes.

496 records 13/34 page Previous Next First page 上5页 1112131415 下5页 Last page